ERBB2 and triple-negative breast carcinoma: Second, pCR has prognostic value only in more aggressive breast cancer subtype such as Luminal B (HER2-negative), HER2-positive (non-luminal) and triple-negative breast cancers, but not in luminal A subtype [24].